Directed Topical Drug Delivery for Treatment for PASC Hyposmia
Status:
COMPLETED
Trial end date:
2024-10-07
Target enrollment:
Participant gender:
Summary
This is a phase II randomized, double-blinded, placebo-controlled study to evaluate the efficacy of topical intranasal treatment of beclomethasone vs. placebo for improved olfactory function.